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Mitophagy is central to mitochondrial and cellular
homeostasis and operates via the PINK1/Parkin
pathway targetingmitochondria devoid ofmembrane
potential (DJm) to autophagosomes. Although mi-
tophagy is recognized as a fundamental cellular
process, selective pharmacologic modulators of
mitophagy are almost nonexistent. We developed
a compound that increases the expression and
signaling of the autophagic adaptor molecule P62/
SQSTM1 and forces mitochondria into autophagy.
The compound, P62-mediated mitophagy inducer
(PMI), activates mitophagy without recruiting Parkin
or collapsingDJm and retains activity in cells devoid
of a fully functional PINK1/Parkin pathway. PMI
drives mitochondria to a process of quality control
without compromising the bio-energetic compe-
tence of the whole network while exposing just those
organelles to be recycled. Thus, PMI circumvents the
toxicity and some of the nonspecific effects associ-
ated with the abrupt dissipation of DJm by iono-
phores routinely used to induce mitophagy and
represents a prototype pharmacological tool to
investigate the molecular mechanisms of mitophagy.
INTRODUCTION
Mitophagy (Kim et al., 2007) is the process by which damaged
or dysfunctional mitochondria are selectively engulfed by auto-
phagosomes and delivered to lysosomes to be degraded and
recycled by the cell. The most well-recognized mechanism gov-
erning the recruitment of autophagosomes to mitochondria is
that driven by the PINK1/Parkin pathway (Narendra and Youle,
2011). The PTEN-induced putative kinase 1 (PINK1) accumu-
lates on the outer membrane of dysfunctional mitochondria
where it triggers the recruitment of the E3 ubiquitin ligase Parkin
(Jin et al., 2010; Narendra et al., 2010; Valente et al., 2004). Once
localized to mitochondria, Parkin ubiquitinates several OMM
proteins that are consequently targeted by P62/SQSTM1 (Geis-
ler et al., 2010). P62 recognizes ubiquitinated substrates andChemistry & Biology 21, 1585–159acts as an adaptor molecule through direct interaction with auto-
phagosome-associated LC3 driving the recruitment of autopha-
gosomal membranes to the mitochondria (Pankiv et al., 2007).
Several alternative Parkin-independent mechanisms are also
suggested to play a part in mitophagy. Damaged mitochondria
can increase FUNDC1 and Nix expression, which may in turn re-
cruit autophagosomes to mitochondria by direct interaction with
LC3 (Liu et al., 2012; Novak et al., 2010). Upon mitochondrial
depolarization, the ubiquitin ligase Smurf1 also targets mito-
chondria to induce mitophagy and, recently, the roles of other
ubiquitin ligases in mitophagy have been described (Ding and
Yin, 2012; Fu et al., 2013; Lokireddy et al., 2012). Currently, there
is a lack of practical and specific pharmacological tools to
manipulate mitophagy and facilitate dissection of the molecular
steps involved in the removal of mitochondria from the network
via this pathway. Mitophagy is now recognized as a fundamental
process in cellular homeostasis because its deficiency is linked
to several neurodegenerative diseases and cancers (de Castro
et al., 2010; Karbowski and Neutzner, 2012; Soengas, 2012;
Wallace, 2012).
The regulation of P62 expression is partly controlled by the
transcription factor Nrf2 (nuclear factor erythroid 2-related factor
2), due to the presence of an antioxidant response element (ARE)
in its promoter region (Ishii et al., 2000; Jain et al., 2010). Thus,
compounds that induce Nrf2 activity have the potential to
enhance P62 expression. A number of electrophilic natural prod-
ucts, including the isothiocyanate compound, sulforaphane, up-
regulate Nrf2 by interfering with its regulator protein, the redox
sensitive ubiquitination facilitator Keap1 (Kelch-like ECH-associ-
ated protein 1) (Cheng et al., 2011; Hayes et al., 2010; Kensler
et al., 2007). Sulforaphane and related compound 1 covalently
modify cysteine residues in the intervening region of Keap1,
which disrupts the ubiquitination, with subsequent destruction
of Nrf2. This results in increased concentrations of Nrf2 and in
the expression of a range of ARE-dependent gene products
involved in phase II metabolism (e.g., glutathione synthesis and
conjugation enzymes, NQO1, heme oxygenase-1, etc.) (Hayes
et al., 2010; Hong et al., 2010; Zhu et al., 2008) and redox control
(e.g., thioredoxin, thioredoxin reductase), in addition to P62 (Jain
et al., 2010; Lau et al., 2010; Ste˛pkowski and Kruszewski, 2011).
Sulforaphane shows activity in a number of preclinical models of
disease prevention, including protection against exposure to
oxidizing agents and carcinogens (Kensler et al., 2013). However,
the isothiocyanate class of compounds, alongwith other reactive6, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1585
Figure 1. PMI Stabilizes Nrf2 and Upregu-
lates P62 Expression Activating Mitophagy
(A) Structures of compounds 1 (sulforaphane) and
2 (PMI); CD is the concentration of compound
causing a doubling of the control level of NQO1
enzymatic activity.
(B) Western blot to show induction of Nrf2-depen-
dent gene products versus time in Hepa1c1c7 cells
(cytoplasmic) exposed to 10 mM PMI.
(C) Induction of NQO1 (NAD(P)H dependent
quinone oxidoreductase-1) by compounds 1 (B)
and 2 (C).
(D) Western blots to demonstrate Nrf2 stabilization
in cells treated with either PMI (10 mM) or, sulfo-
raphane (1 mM) versus time (E) RT-PCR analysis for
estimation of p62 mRNA levels in MEFs following
treatment with PMI versus time. Values are pre-
sented as arbitrary units normalized to 18 s RNA
levels for each sample, n R 3.
(F) Western blot to demonstrate P62 expression
in MEF cells treated with DMSO vehicle control,
10 mM PMI, or 1 mM sulforaphane for 24 hr. B-actin
is shown as a loading control.
(G) Graph shows P62:b-actin ratio band density
analysis, n = 3.
(H) Representative confocal images of b-subunit
staining to highlight mitochondrial density in MEF
cells treated with DMSO vehicle control or 10 mM
PMI for 24 hr.
(I) Graph shows average mitochondrial area as a
percentage of cell size, nR 50.
(J) Western blot to demonstrate reduction in
MTCO1 levels following 4 hr FCCP or 24 hr PMI
exposure.
(K) Graph shows MTCO1:Tubulin ratio band den-
sity analysis normalized to control, n = 3.
All values are mean ± SEM, *p < 0.05, **p < 0.01,
***p < 0.001.
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Pharmacological Regulation of MitophagyNrf2 inducing agents, is capable of interacting with a range of
other cysteine-containing proteins within the cell, which can
make dissecting their biological activity rather difficult. Based
on this, we postulated that pharmacological inducers of Nrf2
that lack a covalent binding motif may upregulate Nrf2-depen-
dent gene expression (including p62), and thereby have an effect
on mitophagy, but may have less potential for cytotoxicity than
sulforaphane (cytotoxic at concentrations above 10 mM inmouse
embryonic fibroblast [MEF] cells). With this aim in mind, we iden-
tified P62-mediated mitophagy inducer (PMI) (HB229) as a mole-
cule that upregulates P62 via stabilization of Nrf2 and promotes
mitophagy. The compound appears to bypass the upstream
steps of the mitophagic cascade, acts independently from the
collapse of the DJm, and does not mediate any apparent toxic
effects on cells at the concentrations used in the assays.1586 Chemistry & Biology 21, 1585–1596, November 20, 2014 ª2014 Elsevier Ltd All rights rRESULTS
PMI Upregulates Nrf2 and
ARE-Dependent Antioxidant Genes
To investigate the effect of PMI (Figure 1A,
compound 2) on expression of antioxi-
dant proteins, levels of two Nrf2-depen-
dent gene products—heme oxygenase-1(HO-1) and NAD(P)H dependent quinone oxidoreductase-1
(NQO1)—were assayed in mouse Hepa1c1c7 cells over time
with western blotting. In these cells, the maximal level of cyto-
plasmic HO-1 expression was observed after 6 hr of PMI treat-
ment, whereas elevated cytoplasmic NQO1 levels were not
detected until 24 hr after PMI exposure (Figure 1B). Additionally,
the induction of NQO1 enzymatic activity after treatment with the
positive control inducer sulforaphane (Figure 1A, compound 1)
and PMI was assayed. Both the electrophilic Nrf2-inducing
agent sulforaphane and PMI showed similar abilities to induce
NQO1 activity (Figure 1A). Although the CD (concentration
causing a 2-fold induction of NQO1) was greater for PMI
(0.6 mM) compared to sulforaphane (0.3 mM), the maximal induc-
tion of NQO1 at 10 mM was higher for PMI (3.7-fold) than sulfo-
raphane (3.4-fold) (Figure 1C). To further understand the kineticseserved
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Pharmacological Regulation of Mitophagyof Nrf2 activation, wemonitored cellular Nrf2 levels in MEFs after
treatment with PMI or sulforaphane over time as an indication of
Nrf2 stabilization. With PMI treatment, maximum Nrf2 levels
were observed after 6 hr and remained elevated at 24 hr after
exposure. In contrast, incubation with sulforaphane produced
a maximum elevation of Nrf2 at 3 hr that had diminished at
6 and 24 hr, although not back to the level of the control
(Figure 1D).
Encouragedby these initial findings,wesought to test thecapa-
bility of PMI to upregulate the Nrf2-dependent protein P62, an
autophagic adaptor, deregulation of which is linked to several
neurological pathologies (Geetha et al., 2012; Salminen et al.,
2012). After exposure of MEF cells to 10 mM PMI or 1 mM sulfo-
raphane, we monitored p62mRNA levels over time using quanti-
tative RT-PCR. There was a significant increase in p62 mRNA
levels after 9 hr ofPMI treatment (Figure1E).Western blot analysis
of cell lysates after 24 hr revealed cytosolic P62 protein levels in
PMI-treated cells had increased 1.8-fold compared to untreated
cells (Figures 1F and 1G), an increase statistically indistinguish-
able from the effect of sulforaphane (2.1-fold). Because P62 has
amajor role inmitochondrial autophagy, we investigatedwhether
pharmacologically induced P62 overexpression could influence
both macro and mitochondrial type autophagy induction.
PMI Promotes Mitochondrial LC3 Recruitment and
Network Refinement
Wemonitored the conversion of LC3B-I to the lipidated LC3B-II in
the cytoplasmic fraction of PMI- and vehicle-treated MEFs (Ka-
beya et al., 2000). Immunoblot analysis revealed no differences
between the two treatments (Figures S1A and S1B available on-
line). This experiment was repeated in the presence of Bafilomy-
cin A1, which prevents the maturation of autophagic vacuoles as
it inhibits the fusion of autophagosomes with lysosomes (Yoshi-
mori et al., 1991), and is therefore a useful pharmacological tool
to further investigate whether PMI interferes with the activation
of general autophagy. However, in these experimental condi-
tions, the level of LC3 lipidation (Klionsky et al., 2012) also re-
mained unchanged after exposure to PMI, suggesting that PMI
does not trigger any upregulation of general cellular autophagy.
Although general autophagy appeared unaffected following
PMI exposure, we were curious to test the effect of PMI on the
specific removal of mitochondria by autophagy and hence the
participation of P62 in mitophagy (Ding et al., 2010; Geisler
et al., 2010; Huang et al., 2011). We initially examined the density
of the mitochondrial network by immunofluorescence (Figures
1H and 1I). Cells treated with PMI for 24 hr were compared with
untreated cells and a reduction in the network size measured
via staining of the F1Fo-ATPsynthase (Abrahams et al., 1994)
was noticeable in PMI-exposed cells, consistent with an alter-
ation of mitochondrial network structure by the activation of
selective autophagy. Additionally we monitored the levels of the
mitochondrial inner membrane protein cytochrome c oxidase
subunit I (CO1 orMTCO1) (Capaldi, 1990) after PMI and carbonyl
cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) (Heytler
and Prichard, 1962) treatment as an indication of mitochondrial
clearance (Figure 1J). Both PMI and FCCP treatment reduced
the levels of MTCO1, although this was more pronounced with
FCCP (Figure 1K). Unlike PMI treatment, exposure to sulforaph-
ane did not cause a reduction in MTCO1 levels (Figures S1CChemistry & Biology 21, 1585–159and S1D). To further assess the role of LC3, we examined
LC3-II levels in mitochondrial fractions with western blotting.
Increased mitochondrial LC3-II was observed in cells treated
with both PMI and FCCP (Figures 2A and 2B) whereas in
p62/ MEF cells, this increase was not detected (Figures 2C
and 2D). Additionally we monitored the colocalization of mito-
chondria and LC3B inMEFsusing high-resolution confocal imag-
ing (Figure 2E). Under resting conditions, cells treated with PMI
showed a dramatic increase in mitochondrial LC3B colocaliza-
tion (PMI-DMSO: 3.31 ± 0.54 normalized fluorescence, units
[n.f.]) compared to untreated conditions (control-DMSO: 1.00 ±
0.17 n.f.). However, when mitophagy was induced with FCCP,
the increase in colocalization attributed to PMI was normalized;
colocalization coefficients for FCCP-stimulated cells in both
controls and PMI-treated conditions were approximately equal
(control-FCCP 1.64 ± 0.20; PMI-FCCP 1.69 ± 0.18 n.f.); yet, as
expected, with a significant induction of mitophagy compared
to untreated conditions (control-DMSO: 1.00 ± 0.17 n.f.)
(Figure 2F). In cells lacking Nrf2 (Nrf2/ MEF), the observed in-
crease in mitochondrial LC3 colocalization attributed to PMI
was abolished (Figures S1E and S1F).
PMI Acts Downstream of the PINK1/Parkin Signaling
Pathway
LC3-containing autophagosomes can be efficiently recruited
to mitochondria by P62 (Ding et al., 2010; Geisler et al., 2010;
Huang et al., 2011). To investigate if PMI treatment corre-
sponded with increased mitochondrial-associated P62, a similar
confocal imaging experiment was performed (Figure 3A) to mea-
sure colocalization of P62 with the mitochondrial network. In this
case, a similar trend was observed (Figure 3B): under basal
conditions, PMI-treated cells showed a substantial increase in
mitochondrial P62 colocalization, relative to control, whereas
this effect was normalized by addition of FCCP (control-DMSO
1.00 ± 0.10; PMI-DMSO 3.15 ± 0.33; control-FCCP 2.08 ±
0.28; PMI-FCCP 1.70 ± 0.27).
During PINK1/Parkin-mediated mitophagy, mitochondrial P62
association occurs in response to Parkinmediated ubiquitination
of OMM substrates (Jin and Youle, 2012). To examine whether
the observed mitochondrial recruitment of P62 and LC3B were
a consequence of a PMI-induced relocation of Parkin, further
imaging experiments were performed (Figure 3C). In this case,
MEFs incubated with PMI showed no increase in mitochon-
drial Parkin translocation compared to control (control-DMSO
1.00 ± 0.75; PMI-DMSO 0.88 ± 1.27). Instead, exposure to
FCCP initiated a significant relocation of Parkin to mitochondria,
in both untreated and PMI treated cells (control-FCCP 66.91 ±
24.22; PMI-FCCP 71.30 ± 14.38) (Figure 3D). This trend was
inconsistent with that observed for LC3B and P62, suggesting
that the action of PMI may occur downstream of Parkin. To
further test this hypothesis, we assayed mitochondrial LC3 co-
localization in Parkin knockdown MEFs and in pink1 knockout
SH-SY5Y (Figures 4 and 5). Notably, in both cases, mitophagy
was increased by PMI (Figure 4, wild-type [WT]: control-DMSO
1.00 ± 0.16; PMI-DMSO 1.65 ± 0.24; Parkin K/D: control-
DMSO 0.44 ± 0.12; PMI-DMSO 1.12 ± 0.13 n.f.) (Figure 5, WT:
control-DMSO 1.00 ± 0.10; PMI-DMSO 1.82 ± 0.21; pink1/:
control-DMSO 0.66 ± 0.05; PMI-DMSO 1.11 ± 0.06; control-
FCCP 1.23 ± 0.07 PMI-FCCP 1.84 ± 0.11 n.f.).6, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1587
Figure 2. PMI Drives LC3 Mitochondrial
Recruitment
(A and B) Western blot highlighting increased LC3-
II in the mitochondrial fraction of WT MEFs treated
with FCCP (A) and PMI quantified in (B); n = 3.
(C and D) Western blot highlighting no increase
in LC3-II in the mitochondrial fraction of p62/
MEFs treated with FCCP (C) and PMI quantified in
(D) n = 3.
(E) Representative images of LC3 localization in
MEF cells treated with DMSO vehicle control or
10 mM PMI for 24 hr, before and after treatment
with FCCP (20 mM) for 4 hr. Scale bar represents
10 mm. A magnification of the merge images is
shown in areas demarcated by the white box.
(F) Quantification of the degree of LC3:b-subunit
colocalization in MEF cells. All values are mean ±
SEM, *p < 0.05, **p < 0.01, ***p < 0.001.
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Pharmacological Regulation of MitophagyThis result suggests that PMI is still able to trigger mitophagy
in the absence of PINK1 or Parkin, but also highlights that an
intact PINK1/Parkin signaling pathway leads to more efficient
mitochondrial clearance when triggered by PMI. This experi-
mental outcome led us to investigate the effect of PMI on mito-
chondrial poly-ubiquitination.
PMIPositively AffectsMitochondrial Poly-Ubiquitination
and Coupling
Poly-ubiquitination of mitochondrial OMM proteins by ubiquitin
ligases flags damaged mitochondria for destruction (Geisler
et al., 2010). When the mitochondrial fractions of cells treated
with PMI and FCCP were analyzed for ubiquitination (Figure 6A),
an increased level was observed compared to control conditions
(Figure 6B). However, as per the previous analyses, an additive
effect in cells treated with both PMI and FCCP was not detected
(control-DMSO 1.00 ± 0.00; PMI-DMSO 2.11 ± 0.84; control-
FCCP 2.89 ± 1.51 PMI-FCCP 2.66 ± 1.09).
To further elucidate the mechanism by which PMI may be
inducing mitophagy we tested aspects of mitochondrial physi-
ology, which are directly involved in the activation of the process
such as dissipation of the mitochondrial membrane potential
(DJm). DJm was monitored in PMI-treated cells with tetrame-
thylrhodamine, methyl ester (TMRM), using signal intensity as a
function of membrane potential (Figures 6C and 6D). Notably,1588 Chemistry & Biology 21, 1585–1596, November 20, 2014 ª2014 Elsevier Ltd All rights rcells incubated with PMI had a higher
resting DJm (2.22 ± 0.14 n.f.) when
compared to control cells (3.62 ± 0.31
n.f.), whereas the rate of FCCP-induced
depolarization of DJm was not affected
(Figure 6E).
Along with the measurements of DJm,
we then explored redox signaling. An
excess of reactive oxygen species (ROS)
may function as an autophagy trigger
(Scherz-Shouval and Elazar, 2011) and
dysfunctional mitochondria that overpro-
duce ROS, are indeed selectively tar-
geted by mitophagy (Kim et al., 2007).
We therefore investigated the effect ofPMI on mitochondrial and cellular ROS. Superoxide production
was assayed in cells treated with PMI for 24 hr by monitoring
the oxidation of the fluorescent probes mitoSOX and DHE to
monitor mitochondrial and cytosolic ROS, respectively. While
no disparity in cytosolic ROS production (Figure 6F) between
treated and control cells was observed, ROS within mitochon-
dria (Figure 6G) appearedmoderately increased in cells exposed
to PMI (control: 1.00 ± 0.04; PMI: 1.24 ± 0.09). A possible expla-
nation of this is that PMI, by promoting segregation of defective
mitochondria from the network via autophagy, could leave only
those that are fully polarized, resulting in an overall increased
rate of respiration within the remaining mitochondria. This may
lead to the observed increase in mitochondrial ROS. This excess
however is undetectable at the cytosolic level, possibly due to
the concomitant upregulation of antioxidant mechanisms.
DISCUSSION
The research devoted to the mechanisms underlying mitophagy
has not been matched by the development of pharmacological
tools to regulate the process. The prototypical approach to
trigger mitophagy is based on the application of chemical iono-
phores: FCCP or carbonyl cyanide m-chlorophenyl hydrazone.
These agents permeabilize the inner mitochondrial membrane
to H+, destroying the H+ gradient, and in doing so, the electroneserved
Figure 3. PMI-Induced Mitochondrial Re-
cruitment of P62 Is Parkin Independent
(A) Representative images of P62 localization in
MEF cells treated with DMSO vehicle control or
10 mM PMI for 24 hr, before and after treatment
with FCCP (20 mM) for 4 hr. Scale bar represents
10 mm. A magnification of the merge images is
shown in areas demarcated by the white box.
Scale bar represents 10 mm.
(B) Quantification of the degree of p62:b-subunit:
colocalization in MEF cells, n > 30.
(C) Representative images of Parkin localization in
MEF cells treated with DMSO vehicle control or
10 mM PMI for 24 hr, before and after treatment
with FCCP (20 mM) for 4 hr. Scale bar represents
10 mm. A magnification of the merge images is
shown in areas demarcated by the white box.
Scale bar represents 1 mm.
(D) Quantification of the degree of parkin:b-subunit
colocalization in MEF cells, n > 30. All values are
mean ± SEM, **p < 0.01, ***p < 0.001.
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Pharmacological Regulation of Mitophagytransport chain of the oxidative phosphorylation system (Hirose
et al., 1974). Although this protocol triggers fast and efficient
depolarization of the organelle and PINK1/Parkin pathway acti-
vation (Kawajiri et al., 2010; Matsuda et al., 2010; Narendra
et al., 2010), it has little physiological significance and has a
number of adverse downstream effects (Padman et al., 2013).
Recently, Jin and Youle have elegantly shown that the accumu-
lation of misfolded proteins in mitochondria may suffice as a
physiological molecular trigger for mitophagy activation without
collapsing the DJm (Jin and Youle, 2013). Additionally, the dis-
covery that cardiolipin externalization on mitochondria acts as
a surface marker of dysfunctional organelles (Chu et al., 2013)
highlights the need for pharmacological tools acting by a
different mechanism to ionophores, to better dissect the contri-
bution of inner mitochondrial pathways to the efficiency of
mitophagy.
We therefore identified a compound that promotes the upre-
gulation of P62 via stabilization of Nrf2 within treated cells (Baird
and Dinkova-Kostova, 2011). This prototypemolecule, which we
called PMI, increases the expression of Nrf2-dependent geneChemistry & Biology 21, 1585–1596, November 20, 2014 ªproducts including P62, HO1, and NQO1
without perturbing mitochondrial func-
tion, the latter effect appears to distin-
guish the compound from some of the
reported effects of sulforophane that ex-
ploits the same pathway. PMI increases
the recruitment of LC3 to mitochondria
without alteration to its lipidation or flux,
an indication that this is not an effect on
macro-autophagy (Figures 2B, 2F, 3B,
and S1B). The absence of increased
LC3 in the mitochondrial fractions of
PMI-treated p62/ MEFs serves to
confine the effects to those associated
with the presence of P62 (Figures 2B
and 2D). This is further supported by the
data from Nrf2/ MEFs in which PMI-
induced recruitment of LC3 to mitochon-dria is lost as expected, possibly due to the diminished P62
levels relative to the WT cells (Figures S1E and S1F).
Notably, the mitochondrial relocalization of P62 and LC3 trig-
gered by PMI was partially reduced when FCCP was added,
suggesting that these two compounds may antagonize each
other. By increasing P62 levels, PMI may promote the maximal
recruitment of the ‘‘available’’ P62 to mitochondria, and,
although the integrity of the PINK1/Parkin pathway (Kawajiri
et al., 2010) is important for its action (see data in Figures 4
and 5), this is not its first site of intervention (Figures 3C and
3D). In cells challenged by PMI, FCCP may therefore drive a
further stress by depolarizing DJm that may become unsustain-
able for the autophagic machinery, thus diminishing the efficacy
of PMI (Figures S1A and S1B). Nevertheless, simultaneous expo-
sure to FCCP and PMI does not affect mitochondrial ubiquitina-
tion (Figures 6A and 6B), which was increased by PMI in line with
the evidence indicating that P62 promotes amore dynamic ubiq-
uitination of dysfunctional mitochondria by activating the ubiqui-
tin ligase activity of TRAF6 that binds and stabilizes PINK1 on de-
polarizedmitochondria (Murata et al., 2013; Wooten et al., 2005).2014 Elsevier Ltd All rights reserved 1589
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Figure 4. In Parkin Knockdown Cells, PMI Promotes LC3 Mitochondrial Accumulation
(A) Representative images of LC3 localization in WT and Parkin knockdown MEF cells treated with DMSO vehicle control or 10 mM PMI for 24 hr. Scale bar
represents 10 mm.
(B) A magnification of the merged images is shown in areas demarcated by the white box. Quantification of mitochondrial LC3 localization in WT and Parkin
knockdown MEF cells treated with DMSO vehicle control or 10 mM PMI for 24 hr, n > 30. All values are mean ± SEM, **p < 0.01.
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Pharmacological Regulation of MitophagyAlthough we cannot rule out the possibility that the abrupt
collapse of mitochondrial respiration caused by FCCP could
be detrimental to PMI activity, the data obtained in (1) MEFs tran-
siently downregulated for Parkin (MEF Parkin KD) as well as in (2)
SH-SY5Y cells devoid of PINK1 (SH-SY5Y pink1 KO) highlight an
alternative mechanism of action for PMI that is still capable of
promoting mitochondrial recruitment of LC3 even if the PINK1/
Parkin pathway is defective (Figures 4 and 5).
In the workingmodel depicted in Figure 7, we suggest that PMI
determination of mitophagy may be made possible by redundant
mitochondrial ubiquitination mechanisms that we have not
identified but that could be the similar to those exploited by cells
endogenously devoid of Parkin (e.g., HeLa) but that still preserve
mitochondrial quality control (Denison et al., 2003; Pawlyk et al.,
2003). The upregulation of the P62 pathway may represent a
compensatory mechanism for defective mitophagy, making
compounds related to PMI potential tools to restore mitophagy
in pathological conditions in which the PINK1/Parkin pathway is
impaired such as in Parkinson disease (Chu, 2010; Narendra
et al., 2009). The null effect on mitophagy recorded for sulforaph-
ane, despite its upregulation of P62 is intriguing. Sulforaphane
and PMI have different time-dependent effects on Nrf2 stabiliza-
tion, PMI has a slower onset of action, but a more sustained
effect (Figure 1D), which may contribute to their differing effects
on mitophagy. There is some evidence from the literature that
sulforaphane has additional effects on mitochondria and mito-
chondrial biogenesis (Negrette-Guzma´n M. et al., 2013), so it is
possible that these may influence the mitophagic process. Alter-1590 Chemistry & Biology 21, 1585–1596, November 20, 2014 ª2014natively, events in addition toP62overexpressionmaybe respon-
sible for the effects of PMI. Further experimentswill be required to
fully elucidate and clarify the mode of action, and the factors that
distinguish PMI from sulforaphane in the area of mitophagy.
PMI-treated mitochondria display an increased superoxide
metabolism, (Suski et al., 2012) (Figure 6G) which, in light of
the parallel effects on mitochondrial network appearance (Fig-
ure 1H) and DJm (Figures 6C and 6D), could indicate an
improved oxidative-respiratory capacity; data that are consis-
tent with recent reports (Holmstro¨m et al., 2013). The accompa-
nying respiratory metabolic by-products remain undetectable in
the cytoplasm, possibly due to the Nrf2-mediated upregulation
of antioxidant responses as demonstrated by increases in
ARE-dependent HO1 and NQO1 expression (Figures 1B–1D).
Based on these in vitro findings, PMI is a molecule that drives
mitochondria to a process of quality control without compro-
mising the bio-energetic competence of the whole network but
exposing just those organelles to be recycled. By acting
alternately from FCCP, PMI could be a useful tool to define the
contribution of molecules regulating mitophagy and illuminate
the coordination between mitochondrial and nonmitochondrial
events that drive execution of the process.
SIGNIFICANCE
Mitochondrial quality control is a fundamental process in
cellular homeostasis, and its deficiency is linked to several
neurodegenerative diseases and cancers. Despite this, theElsevier Ltd All rights reserved
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Figure 5. In PINK1 Knockout Cells, LC3 Is Recruited to Mitochondria by PMI
(A) Representative images of LC3 localization inWT and Pink1 knockout SH-SY5Y treated with DMSO vehicle control or 10 mMPMI for 24 hr. Scale bar represents
10 mm. A magnification of the merge images is shown in areas demarcated by the white box.
(B) Quantification of mitochondrial LC3 localization inWT and Pink1 knockout SH-SY5Y cells treated with DMSO vehicle control or 10 mMPMI for 24 hr, n > 30. All
values are mean ± SEM, **p < 0.01.
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Pharmacological Regulation of Mitophagydiscrete mechanisms, regulatory pathways, and impact on
cellularphysiologyarestill far frombeingelucidated. Thecur-
rent canonical methods to triggermitophagy in vitro typically
involve theabrupt depolarizationofmitochondrialmembrane
potential (DJm) using ionophores such as carbonyl cyanide
m-chlorophenyl hydrazone or FCCP that mediate various
detrimental effects on several other cellular processes. PMI
is a pharmacological agent that can trigger mitophagy while
leaving DJm intact. Therefore, PMI has enormous potential
asa tool to furtherstudy thefinely tunedprocessofmitochon-
drial quality control and dysregulation in disease states in a
more physiologically relevant background.
EXPERIMENTAL PROCEDURES
Chemistry and Analytical Data
Sulforaphane was purchased from Sigma-Aldrich (S6317). PMI (1-(3-iodo-
phenyl)-4-(3-nitrophenyl)-1,2,3-triazole) was synthesized from commercially
available starting materials in four solution-phase synthetic steps.
1H and 13C nuclear magnetic resonance (NMR) spectra were recorded on a
Bruker Avance 400 instrument using solvent residuals as internal references.
The following abbreviations are used: singlet (s), doublet (d), doublet of dou-
blets (dd), triplet (t), doublet of triplets (dt), and multiplet (m). UCL School of
Pharmacy provided high-resolutionmass spectrometry and elemental analysis
services. Melting points (mp, uncorrected) were determined using a Stuart
Melting Point Apparatus SMP30 (Bibby Scientific). Thin-layer chromatography
analysis was carried out on silica gel (Merck 60F-254) aluminum backed plates
with depiction at 254 and 365 nm. Preparative flash chromatography was car-
ried out with Merck silica gel (Si 60, 40–63 mm). Reagents, chemicals, and dry
solvents (DMF) were purchased from Sigma-Aldrich unless otherwise stated.Chemistry & Biology 21, 1585–159Liquid chromatography-mass spectrometry (LC-MS) analyseswere performed
on a Waters Micromass ZQ instrument coupled to a Waters 2695 high-perfor-
mance liquid chromatography (HPLC) with a Waters 2996 PDA (LC-MS instru-
ment). Waters Micromass ZQ parameters used were capillary (kV), 3.50; cone
(V), 30; extractor (V), 3.0; source temperature (C), 120; desolvation tempera-
ture (C), 350; cone flow rate (l/hr), 80; desolvation flow rate (l/hr), 650. Analytical
reverse-phase HPLC was carried out on a Phenomenex Onyx Monolithic C-18
column 503 4.6 mm. HPLC experiments were performed with gradient condi-
tions: 95% solvent A, 5% solvent B for 1 min, then from 5% B to 95% B over
4 min (total run time 5 min, flow rate 1.5 ml/min) (solvent A [H2O containing
0.1% v/v formic acid] and solvent B [MeCN containing 0.1% v/v formic acid]).
1-Ethynyl-3-Nitrobenzene
To a solution of 1-bromo-3-nitrobenzene (2.0 g, 9.90 mmol, 1.0 equiv.) in dry
DMF (5 ml) was added to diethylamine (10 ml); nitrogen gas was bubbled
through the resulting solution for 20 min. CuI (8.4 mg, 0.04 mmol, 0.4%mol),
Pd(PPh3)4 (125.9 mg, 0.11 mmol, 1.1%mol), and trimethylsilylacetylene
(1.53 ml, 11.00 mmol, 1.11 equiv.) were then added and the resulting mixture
was submitted to the following microwave heating sequence: prestirring for
30 s, then 1 hr at 120C (Wang et al., 2007). The resulting mixture was poured
into aqueous HCl (1 M, 60 ml) and extracted with DCM. The organic was
washed with aqueous HCl (1 M, 50 ml) and brine (saturated solution, 50 ml),
dried over MgSO4, filtered, and concentrated under reduced pressure. The
residue was purified by column chromatography on silica gel (hexane/ethyl
acetate 9/1) to afford 3-(trimethylsilylethynyl)nitrobenzene as a yellow solid
(1.05 g, 48.5% chemical yield). Rf(hexane/EtOAc 9:1) = 0.55;
1H-NMR
(400 MHz, CDCl3): d (ppm) 8.3 (t, J = 1.6 Hz, 1H), 8.16 (ddd, J = 1.2, 2.2,
8.0 Hz, 1H), 7.75 (dt, J = 1.2, 8.0 Hz, 1H), 7.48 (t, J = 8.0 Hz, 1H), 0.27
(s, 9H); 13C-NMR (100 MHz, CDCl3): d (ppm) 148.0, 137.5, 129.2, 126.8,
125.0, 123.1, 102.1, 97.6, 0 (3C); and LC-MS 100%, 3.60 min.
3-(trimethylsilylethynyl)nitrobenzene (317.0 mg, 1.45 mmol, 1.0 equiv.) was
dissolved inmethanol (15ml).K2CO3 (359.0mg,2.6mmol, 1.8equiv.)wasadded
and the suspension was stirred under N2 at RT for 2.5 hr. The mixture was6, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1591
Figure 6. PMI Mediates Poly-Ubiquitination
of Mitochondria and Increases DJm
(A) Western blot of mitochondrial fractions, high-
lighting mitochondrial ubiquitination in control or
PMI-treated MEF cells before and after treatment
with 20 mM FCCP.
(B) The graph shows total ubiquitin band density
analysis relative to b-subunit loading control, n = 3.
(C) Representative confocal images depicting dif-
ferences in DJm when in MEF cells treated with
DMSO vehicle control or 10 mM PMI for 24 hr and
loaded with the cationic mitochondria selective
probe TMRM (red) for 30min. Scale bar represents
10 mm.
(D and E) Mean basal TMRM fluorescence quan-
tification n > 10 (D) and shows representative
traces of the effects of FCCP on mitochondrial
membrane potential in treated with DMSO vehicle
control or 10 mM PMI for 24 hr (E).
(F) Values of cytosolic ROS accumulation data
collected in MEF cells by recording the rate of
nuclear uptake of the O2
 sensitive dye, dihy-
droethidium (DHE), n > 30.
(G) Mitochondrial ROS generation collected in
MEF cells by recording fluorescence intensity
of O2
 sensitive, mitochondrial-specific dye,
MitoSOX, n > 20. All values are mean ± SEM, *p <
0.05 **p < 0.01.
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with EtOAc. The organic phase was washed with brine, dried over MgSO4,
filtered, and concentrated under reduced pressure to afford1-ethynyl-3-nitro-
benzene as a brown oil (180.0 mg, 85% chemical yield). Rf (hexane/EtOAc
9:1) = 0.47; 1H-NMR (400 MHz, CDCl3): d (ppm) 8.32 (t, J = 2.0 Hz, 1H), 8.19
(ddd, J = 1.2, 2.4, 8.0 Hz, 1H), 7.78 (dt, J = 1.2, 8.0 Hz, 1H), 7.51 (t, J = 8.0 Hz,
1H), 3.22 (s, 1H); 13C-NMR (100 MHz, CDCl3): d (ppm) 148.1, 137.7, 129.4,
127.0, 123.9, 123.5, 81.1, 79.9; and LC-MS 100%, 3.15 min.
1-Azido-3-Iodobenzene
3-Iodo-aniline (500.0 mg, 0.275 ml, 2.28 mmol, 1.0 equiv.) was suspended in
water (10 ml) and aqueous HCl (1 ml, 10% v/v) was added and the solution1592 Chemistry & Biology 21, 1585–1596, November 20, 2014 ª2014 Elsevier Ltd All rights rcooled to 0C. A solution of NaNO2 (189.0 mg,
2.74 mmol, 1.2 equiv.) in water (2 ml) was added
dropwise at 0Cand themixture stirred for a further
20 min (Faucher et al., 2002). A solution of NaN3
(223.0 mg, 3.43 mmol, 1.5 equiv.) in water (2 ml)
was added dropwise at 0C and the resulting sus-
pension stirred for a further 3 hr. The solution was
extracted with Et2O; the organic phase washed
with water and saturated brine, then dried over
MgSO4, filtered, and evaporated to afford 1-
azido-3-iodobenzene as an orange oil (525.8 mg,
94% chemical yield). 1H-NMR (400 MHz, CDCl3):
d (ppm) 7.46 (dt, J = 1.2, 7.6 Hz, 1H), 7.37
(t, J = 2.0 Hz, 1H), 7.06 (t, J = 8.0 Hz, 1H), 6.98
(ddd, J = 1.2, 2.0, 8.0 Hz, 1H); 13C-NMR (100
MHz, CDCl3): d (ppm) 141.3, 133.9, 131.0, 127.9,
118.4, 94.6.
1-(3-Iodophenyl)-4-(3-Nitrophenyl)-
1,2,3-Triazole
1-Ethynyl-3-nitrobenzene (40.0 mg, 0.27 mmol,
1.0 equiv.) was suspended in tert-butanol
(1.1 ml). An aqueous solution of CuSO4 (2.2 mg,
9.0 mmol, 0.033 equiv.; i.e. 0.54 ml from a
4.12 mg/ml solution in water), an aqueous solution
of ascorbic acid (4.8 mg, 0.027 mmol, 0.1 equiv.;i.e. 0.55 ml from an 8.7 mg/ml solution in water) and 1-azido-3-iodobenzene
(66.6 mg, 0.27 mmol, 1.0 equiv.) were then added. The mixture was submit-
ted to the following microwave heating sequence: pre-stirring for 30 s, fol-
lowed by stirring at 130C for 30 min. The resulting suspension was diluted
with water and filtered; the residue was washed with water and dried under
vacuum to afford 1-(3-iodophenyl)-4-(3-nitrophenyl)-1,2,3-triazole as a yellow
solid (57.0 mg, 53% chemical yield). mp 211-216C (decomp.); 1H-NMR (400
MHz, DMSO-d6): d (ppm) 9.65 (s, 1H), 8.74 (t, J = 2.0 Hz, 1H), 8.39 (dt, J = 1.2,
8.0 Hz, 1H), 8.35 (t, J = 2.0 Hz, 1H), 8.25 (ddd, J = 0.8, 2.0, 8.0 Hz, 1H), 8.03
(ddd, J = 0.8, 2.0, 8.0 Hz, 1H), 7.90 (dt, J = 1.2, 8.0 Hz, 1H), 7.83 (t, J = 8.0 Hz,
1H), 7.44 (t, J = 8.0 Hz, 1H);13C-NMR (125 MHz, DMSO-d6): d (ppm) 148.3,eserved
Figure 7. The Proposed Working Model
for PMI
(A) In healthy WT cells, a proportion of mitochon-
dria will be destined for destruction due to age,
damage, or dysfunction. Parkin-mediated ubiq-
uitination (orange spheres) primes these mito-
chondria to enter the autophagic pathway and
available P62 links them to LC3 (green spheres)
and the growing autophagosome.
(B) In PMI-treated cells, P62 is more abundant
therefore able to drive mitochondria into auto-
phagy with increased efficiency.
(C) In cells where Parkin expression is reduced, a
reduced number of mitochondria are primed for
autophagy, so although P62 is overexpressed, the
efficiency of mitophagy is reduced.
(D) Finally, in cells devoid of PINK1, Parkin is not
recruited to mitochondria; however, redundant/
alternative ubiquitin ligases may still be capable of
ubiquitinating mitochondria, which can then be
driven into autophagy by P62, albeit with reduced
efficiency.
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Pharmacological Regulation of Mitophagy145.3, 137.4, 137.2, 131.75, 131.7, 131.2, 130.7, 128.0, 122.8, 121.1, 119.5,
119.2, 95.4; LC-MS 100%, 3.68 min; HRMS (TOF ES+): calculated for
C14H10IN4O2: 392.9849, found: 392.9846; elemental analysis: calculated
for: C14H9IN4O2: C 42.88%, H 2.31%, N 14.29%, found: C 42.86%, H
2.30%, N 14.01%.
Cell Culture and Transfections
MEFs andSH-SY5Y (SHY) cells weremaintained at 37C under humidified con-
ditionsand5%CO2andgrown inDulbecco’smodifiedEaglemedium(LifeTech-
nologies, 41966-052) supplemented with 10% fetal bovine serum (Life Technol-
ogies, 10082-147), 100 U/ml penicillin, and 100 mg/ml streptomycin (Life
Technologies, 15140-122). Cells plated on glass coverslips/10 cm dishes at a
10%–20% confluence 1 day prior to transfection were transiently transfected
with the genes of interest or siRNA using a standard Ca2+ phosphate method
as described previously (Morelli et al., 2003). Cells were used in experiments
36–48 hr after transfection. To knock down parkin expression, species-depen-
dent pre-designed siRNA was used—Murine Park2 target sequence: AC
CATTGGGCCTGCTGGTCTA (QIAGEN, SI01369599). Experiments, unless
otherwise indicated, were performed in Dulbecco’s modified Eagle medium
supplementedwith 10%fetal bovineserumor in the following recordingmedium
(RM): 125 mM NaCl, 5 mM KCl, 1 mM NaH2PO4, 20 mM HEPES, 5.5 mM
glucose, 5 mMNaHCO3, and 1 mM CaCl2, pH 7.4. The murine hepatoma Hep-
a1c1c7 cell line was obtained from the European Collection of Cell Culture. The
cells were grown as monolayers and maintained by regular passage in a-MEM
(Hepa1c1c7 cell line) supplemented with 2 mM L-glutamine, 100 units/ml peni-
cillin and 100 mg/ml streptomycin and 10%heat-inactivated fetal bovine serum,
cultured at 37C in a water vapor saturated atmosphere with 5% CO2.
NQO1 Activity Assay
The method used is a modification of the procedure described by Fahey et al.
(2004). Hepa1c1c7 cells were seeded in 96-well plates with a cell density ofChemistry & Biology 21, 1585–1596, November 20, 20142 3 104 cells/200 ml per well. After 12 hr, the cells
were treated with compound or vehicle (final
DMSO concentration 0.1% DMSO) and incubated
for 24 hr. The culture medium was aspirated and
cells lysed using 50 ml/well lysis buffer (0.1%
Tween20 in 2 mM EDTA [pH 7.5]) and the plate
shaken at room temperature for 15 min. The
enzyme reaction mixture (200 ml; 25 mM Tris buffer
[pH 7.5] containing BSA [0.067%], Tween20
(0.01%), FAD (5 mM), G6P (1 mM), NADP (30 mM),G6P dehydrogenase (40 units), MTT (0.03%), and menadione (50 mM)) was
added to each well. After 5 min at room temperature, 40 ml of the stop solution
(10% SDS, final concentration 1.5% SDS) was added to each well and the
plate shaken for 5 s. The absorbance at 595 nm was measured. The back-
ground optical density wasmeasured usingwells containing tissue cultureme-
dium, lysis buffer, and enzyme and stop solutions without Hepa1c1c7 cells.
The optical density values at 595 nm were averaged and the background cor-
rected ratio of optical densities (compound treated/control) was calculated.
DJm Measurements
Cells were loaded with 100 nM tetramethyl rhodamine methyl ester (TMRM)
(Sigma-Aldrich, T5428) in recording medium (125 mM NaCl, 5 mM KCl,
1 mM NaH2PO4, 20 mM HEPES, 5.5 mM glucose, 5 mM NaHCO3, and
1 mM CaCl2, pH 7.4) for 30 min at 37
C. The TMRM dye accumulates in mito-
chondria, and its signal intensity is a function of potential (Scaduto andGrotyo-
hann, 1999). Cells were washed once in recording medium then transferred to
the Zeiss LSM 510 confocal microscope (403 objective) for imaging. After
several minutes of continuous recording at basal conditions, 1 mM FCCP
was added to induce depolarization. Settings were kept constant between
experiments. Mitochondrial regions of interest were selected and the corre-
sponding TMRM fluorescence intensities calculated.
Reactive Oxygen Species Analysis
Cells were incubated with 5 mM dihydroethidium (Life Technologies, D-1168)
or 5 mM mitoSOX (Life Technologies, M-36008) in recording medium
(125 mM NaCl, 5 mM KCl, 1 mM NaH2PO4, 20 mM HEPES, 5.5 mM glucose,
5 mM NaHCO3, and 1 mM CaCl2, pH 7.4) for 30 min at 37
C. Cells were
washed once in recording medium then transferred to a Zeiss LSM 510
confocal microscope (403 objective) for imaging and fluorescence intensity
was measured through continuous recording for at least 10 min. Settings
were kept constant between experiments. Mitochondrial ROIs were selected
and the corresponding fluorescence intensities were calculated.ª2014 Elsevier Ltd All rights reserved 1593
Chemistry & Biology
Pharmacological Regulation of MitophagySubcellular Fractionation
Cells were lysed in cold isotonic buffer (250 mM sucrose, 10 mM KCl, 1.5 mM
MgCl2, 1 mM EDTA, 1 mM EGTA, 20 mM HEPES, pH 7.4) containing protease
inhibitor cocktail (Roche, 05892791001) by passing through a 26 gauge needle
ten times using a 1 ml syringe followed by 20 min incubation on ice. Unbroken
cells and nuclei were removed by centrifugation at 800 3 g for 5 min at 4C.
Supernatants were transferred to fresh tubes and centrifuged at 10,000 3 g
for 10 min at 4C, Subsequent supernatants were collected as the cytosolic
fractions while mitochondrial pellets were washed once in cold isotonic buffer
then centrifuged at 10,0003 g for 10 min at 4C. Finally, mitochondrial pellets
were lysed in lysis buffer (150 mM NaCl, 1% v/v Triton X-100, 20 mM Tris
pH 7.4) for 30 min on ice.
Western Blotting
Sample proteins were quantified using a BCA protein assay kit (Fisher Scien-
tific, 13276818). Equal amounts of protein (10–30 mg for whole cell lysates/
cytosolic fractions; 10 mg for mitochondrial fractions) were resolved on 10%
or 12% SDS-PAGE gels and transferred to nitrocellulose membranes (Fisher
Scientific, 10339574). The membranes were blocked in 3% nonfat dry milk
in 50 mM Tris, 150 mM NaCl, 0.05% Tween 20, pH 7.5 (TBST) for 1 hr, then
incubated with the appropriate diluted primary antibody at 4C overnight:
rabbit a-LC3 (Abcam, ab48394) 1:1,000; mouse a-P62/SQSTM1 (Abcam,
ab56416) 1:20,000; a-GAPDH-Hrp conj. 1:50,000 (Abcam, ab9484); a-ubiqui-
tin (Abcam, ab7780) 1:10,000, mouse a-parkin (Abcam, ab77924) 1:1,000.
Membranes were washed in TBST (3 3 15 min at room temperature [RT])
and then incubated with corresponding peroxidase-conjugated secondary
antibodies (Dako, P0447, P0448) for 1 hr at RT. After further washing in
TBST, blots were developed using an ECL Plus western blotting detection
kit (Fisher Scientific, 12316992). Immunoreactive bands were analyzed by
performing densitometry with ImageJ software.
Blots from Hepa1c1c7 cells were obtained as follows. Following treatment
with 10 mM PMI, cells were harvested at different time intervals. Nuclear and
cytosolic fractions were obtained using NE-PER Nuclear and Cytoplasmic
Extraction Reagents (Thermo Scientific, 78833). Proteins were separated by
electrophoresis on 10% SDS-PAGE gels and transferred onto nitrocellulose
membranes. The blots were blocked with 1% skimmed milk and probed
overnight with the primary antibodies: Heme Oxygenase 1 (Santa Cruz
Biotechnology, sc-10789) polyclonal antibody, NQO1 (Santa Cruz Biotech-
nology, sc-271116) monoclonal antibody, or b-actin (Santa Cruz Biotech-
nology, sc-130657) polyclonal antibody. Following a 2 hr incubation period
with peroxidase-conjugated secondary antibodies, proteins were detected
using enhanced chemiluminescence (Fisher Scientific, 12316992).
Immunofluorescence
Cells were fixed in 4% PFA (10 min, RT) followed by three 5-minute washes in
PBS. Permeabilization was performed with 0.5% Triton-X in PBS (10 min, RT)
followed bywashing. Blocking was carried out for 1 hr at RT in 10%goat serum
and 3% BSA in PBS. Primary antibody incubations were conducted overnight
for 16 hr at 4C in blocking solution as described. After a further wash step,
secondary antibodies were incubated for 1 hr in blocking solution, before a
final wash step. Cells were then mounted on slides with DAPI mounting
medium (Abcam, ab 104139). Cells were stained with the following primary
antibodies: mouse a-b-subunit (Abcam, ab14730) 1:1,000; a-P62/SQSTM1
(Abcam, ab56416) 1:500; a-LC3 (Abcam, ab48394) 1:50, and the following
secondary antibodies: a-mouse Alexa 555 (Life Technologies, A21424)
1:1,000; a-rabbit Alexa 488 (Life Technologies, A11008) 1:1,000.
Quantitative Real-Time PCR
Total RNAwas extracted from the cultured cells using Tri-Reagent (Sigma) and
purified using an RNeasy Mini Kit (QIAGEN). Spectrophotometry was used to
quantify and determine purity (260/280nm ratio) of the total RNA (Nanodrop,
LabTechnologies). One microgram of total RNA was used to synthesize
cDNA in a 20 ml reaction volume as described using the QuantiTect Reverse
Transcription kit (QIAGEN). Gene transcripts were amplified by RT-PCR using
commercially available primer against mouse p62/sqstm1 (Sigma KiCqStart
SYBR Green Primer pair:: M_Sqstm1_3).
Quantitative real-time PCR reactions were performed in the Chromo 4 light
cycler (Biorad). The absolute quantification method was used whereby the1594 Chemistry & Biology 21, 1585–1596, November 20, 2014 ª2014level of gene expression was expressed as a copy number. A standard curve
was generated using known amounts of the DNA PCR product of the gene. A
volume of 2 ml of the cDNA product from the reverse transcription reaction was
used in a total volume of 20 ml SYBR green detection (QIAGEN). The SYBR
green PCR reaction mix constituted of a final concentration of 2.5 mM
MgCl2, 0.1 mM of each primer with the reaction consisting of the following:
an initial 15 min denaturation step at 95C followed by denaturation at 94C
for 15 s, annealing at 55C for 25 s, and extension at 72C for 15 s repeated
for 40 cycles. The DNA standards and samples were run in the same 96-well
PCR plate and the average of each duplicate value was used for subsequent
statistical analyses. All PCR products were checked for specificity and purity
from a melting curve profile performed by the lightcycler software at the end
of each run.
Statistical Analysis
Data are presented as mean ± SEM. One-way ANOVA was used in multiple
group comparisons with Bonferroni’s post hoc test to compare two data
sets within the group and a p value less than 0.05 was considered significant.
All analyses were performed in Microsoft Office Excel 2007. *p < 0.05, **p <
0.01, ***p < 0.001.
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